Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.6498
-0.0182 (-2.72%)
At close: Mar 6, 2026, 4:00 PM EST
0.6103
-0.0395 (-6.09%)
After-hours: Mar 6, 2026, 5:39 PM EST
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $7.15 million as of March 6, 2026. Its market cap has decreased by -63.29% in one year.
Market Cap
7.15M
Enterprise Value
6.50M
1-Year Change
-63.29%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $7.15M, a decrease of -83.75%. That is a compound annual growth rate of -79.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.15M | -21.17% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 896.55B |
| Johnson & Johnson | 591.15B |
| AbbVie | 417.62B |
| AstraZeneca | 312.69B |
| Quoin Pharmaceuticals | 7.13M |
| enVVeno Medical | 7.07M |
| Intelligent Bio Solutions | 7.04M |
| Mustang Bio | 7.00M |